HUSSMAN STRATEGIC ADVISORS, INC.

Position in BIIB — Biogen Inc.

CIK 1179475 ELLICOTT CITY, MD

Position in BIIB

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,537,260

+$3,382,281 QoQ

Shares Held

21,000

+233.3% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

#256

of 1,031 holders

Holding Since

Mar 2020

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HUSSMAN STRATEGIC ADVISORS, INC. holds $8,590,428 across 3 Drug Manufacturers - General names. BIIB ranks #1 (52.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BIIB	Biogen Inc. This page	21,000	$4,537,260
2	AMGN	Amgen Inc	8,400	$3,041,808
3	PFE	Pfizer Inc	42,000	$1,011,360

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,537,260	21,000	+233.3%	Shares	Sole	2026-08-03
2026-03-31	$1,154,979	6,300	0.0%	Shares	Sole	2026-05-11
2024-09-30	$1,221,192	6,300	0.0%	Shares	Sole	2024-11-01
2024-06-30	$1,460,466	6,300	0.0%	Shares	Sole	2024-08-01
2024-03-31	$1,358,469	6,300	0.0%	Shares	Sole	2024-05-01
2023-12-31	$1,630,251	6,300	0.0%	Shares	Sole	2024-02-01
2023-09-30	$1,619,163	6,300	0.0%	Shares	Sole	2023-11-08
2023-06-30	$1,794,555	6,300	-71.0%	Shares	Sole	2023-08-03
2022-06-30	$4,425,498	21,700	+19.2%	Shares	Sole	2022-09-12
2022-03-31	$3,832,920	18,200	+40.0%	Shares	Sole	2022-05-04
2021-12-31	$3,118,960	13,000	+67.7%	Shares	Sole	2022-01-31
2021-09-30	$2,193,172	7,750	+150.0%	Shares	Sole	2021-11-01
2021-06-30	$1,073,437	3,100	-74.8%	Shares	Sole	2021-08-03
2021-03-31	$3,440,925	12,300	0.0%	Shares	Sole	2021-05-03
2020-12-31	$3,011,778	12,300	-31.3%	Shares	Sole	2021-02-01
2020-09-30	$5,077,872	17,900	-0.3%	Shares	Sole	2020-11-02
2020-06-30	$4,802,522	17,950	+38.9%	Shares	Sole	2020-07-31
2020-03-31	$4,089,211	12,925	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.